Furthermore, double-labeling experiments with GFAP, a well-established astrocytic and glioma marker in rodent models, revealed substantial co-localization of BBG with GFAP-positive tumor cells (Figure 3, lower panel). The gene discussed is GFAP; the disease is central nervous system cancer.